Zobrazeno 1 - 10
of 875
pro vyhledávání: '"Birtel, M."'
Publikováno v:
In IFAC PapersOnLine 2016 49(31):85-90
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vezzali, L., Birtel, M. D., Di Bernardoa, G. A., Stathi, S., Crisp, R. J., Cadamuroa, A., Visintin, E. P.
Publikováno v:
Group processes & intergroup relations, 2020, Vol.23(5), pp.643-663 [Peer Reviewed Journal]
A growing body of research has shown that imagined intergroup contact can improve outgroup attitudes. The aim of the present study was to examine the effectiveness of a multifaceted form of imagined contact in counteracting bullying in school childre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______328::2cae6c4bd4cce53cf26dfc3530f0b45d
http://dro.dur.ac.uk/28099/1/28099.pdf
http://dro.dur.ac.uk/28099/1/28099.pdf
Autor:
Birtel M; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Voss RH; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany.; Department of Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany., Reinhard K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Rengstl B; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Ouchan Y; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Michel K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Hayduk N; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Tillmann B; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany., Becker R; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany., Suchan M; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany., Theobald M; Department of Hematology, Oncology, and Pneumology, University Cancer Center (UCT), University Medical Center (UMC) of Johannes Gutenberg University, Mainz, Germany., Oehm P; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany., Sahin U; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH (non-profit), Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, Mainz, Germany.; Department of Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2022 Aug 18; Vol. 2 (8), pp. 827-841. Date of Electronic Publication: 2022 Aug 18 (Print Publication: 2022).
Autor:
Alishah K; Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran.; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Birtel M; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Masoumi E; Department of Immunology, School of Medicine, Tehran University of Medical Science, Tehran, Iran., Jafarzadeh L; Department of Immunology, School of Medicine, Tehran University of Medical Science, Tehran, Iran., Mirzaee HR; Department of Immunology, School of Medicine, Tehran University of Medical Science, Tehran, Iran., Hadjati J; Department of Immunology, School of Medicine, Tehran University of Medical Science, Tehran, Iran., Voss RH; Department of Research Center for Immunotherapy (FZI), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany. Ralf-Holger.Voss@unimedizin-mainz.de., Diken M; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany. mustafa.diken@tron-mainz.de., Asad S; Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran. asad@ut.ac.ir.
Publikováno v:
Journal of translational medicine [J Transl Med] 2021 Nov 27; Vol. 19 (1), pp. 482. Date of Electronic Publication: 2021 Nov 27.
Autor:
Defourny, Ploon1 (AUTHOR), van Sambeek, Nienke2,3 (AUTHOR) vansambeek@eshpm.eur.nl, van de Bovenkamp, Hester2 (AUTHOR), Scheepers, Floortje3 (AUTHOR), Heerings, Marjolijn2 (AUTHOR)
Publikováno v:
BMC Psychiatry. 11/19/2024, Vol. 24 Issue 1, p1-13. 13p.
Autor:
Beck JD; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Birtel M; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Haefner E; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Keil IS; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Reidenbach D; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Salomon N; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Yildiz IG; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Diken M; TRON-Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2020 Apr 02; Vol. 16 (4), pp. 808-815. Date of Electronic Publication: 2019 Nov 11.
Autor:
Reinhard K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Rengstl B; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Oehm P; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Michel K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Billmeier A; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Hayduk N; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Klein O; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Kuna K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Ouchan Y; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Wöll S; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Christ E; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Weber D; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Suchan M; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Bukur T; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Birtel M; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Jahndel V; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Mroz K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Hobohm K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Kranz L; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Diken M; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany., Kühlcke K; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Sahin U; Biopharmaceutical New Technologies (BioNTech) Corporation, BioNTech Cell & Gene Therapies GmbH, BioNTech Innovative Manufacturing Services GmbH, An der Goldgrube 12, 55131 Mainz, Germany. ugur.sahin@biontech.de.; TRON-Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Freiligrathstr. 12, 55131 Mainz, Germany.; Helmholtz Institute for Translational Oncology Mainz, HI-TRON Mainz, Obere Zahlbacher Str. 63, 55131 Mainz, Germany.
Publikováno v:
Science (New York, N.Y.) [Science] 2020 Jan 24; Vol. 367 (6476), pp. 446-453. Date of Electronic Publication: 2020 Jan 02.
Autor:
Canham, Sarah L.1 (AUTHOR) sarah.canham@utah.edu, Weldrick, Rachel2 (AUTHOR), Erisman, Morgan1 (AUTHOR), McNamara, Anne3 (AUTHOR), Rose, Jeffrey N.4 (AUTHOR), Siantz, Elizabeth1 (AUTHOR), Casucci, Tallie5 (AUTHOR), McFarland, Mary M.6 (AUTHOR), Lai, Frank Ho-yin (AUTHOR)
Publikováno v:
Health & Social Care in the Community. 9/27/2024, Vol. 2024, p1-20. 20p.
Autor:
D'Angelo, Martina1 (AUTHOR) steardo@unicz.it, Steardo Jr., Luca1 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Jul2024, Vol. 13 Issue 14, p4000. 12p.